Literature DB >> 8993947

Pulmonary aspergillosis: a spectrum of disease.

L S Broderick1, D J Conces, R D Tarver, C A Bergmann, M A Bisesi.   

Abstract

Although many species of the fungus Aspergillus have been identified, the most common human pathogen is A. fumigatus, which has a worldwide distribution. Although any organ may become infected, pulmonary aspergillosis is the most common manifestation. The spectrum of pulmonary aspergillosis includes saprophytic aspergillomas, allergic bronchopulmonary aspergillosis, chronic necrotizing aspergillosis, and invasive aspergillosis. Immune status of the host, and the presence of underlying lung disease are important in determining the type of pulmonary involvement. Thus, the radiographic findings are variable. This article reviews the various manifestations of pulmonary aspergillosis, including the immune status of the patient, the presence of underlying lung disease, and the radiographic appearance of the different entities.

Entities:  

Mesh:

Year:  1996        PMID: 8993947

Source DB:  PubMed          Journal:  Crit Rev Diagn Imaging        ISSN: 1040-8371


  8 in total

Review 1.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Adhesion of Aspergillus species to extracellular matrix proteins: evidence for involvement of negatively charged carbohydrates on the conidial surface.

Authors:  J A Wasylnka; M M Moore
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis.

Authors:  Kristin J Carpenter; Cory M Hogaboam
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients.

Authors:  M L Uffredi; G Mangiapan; J Cadranel; G Kac
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-25       Impact factor: 3.267

Review 5.  [Infections under immunosuppressive therapy following organ transplantation].

Authors:  L Renders; H Schöcklmann; U Kunzendorf
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

Review 6.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

7.  Fungal Infections of the Lung.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

Review 8.  Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.

Authors:  Philipp Kuhn; Viola Fühner; Tobias Unkauf; Gustavo Marcal Schmidt Garcia Moreira; André Frenzel; Sebastian Miethe; Michael Hust
Journal:  Proteomics Clin Appl       Date:  2016-06-21       Impact factor: 3.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.